Related Announcements

RFA-DK-21-027 -  National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U2C - Clinical Trial Not Allowed)

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice is to inform the applicant community of an increase in funds available and number of anticipated awards for Funding Opportunity Announcement (FOA) RFA-DK-21-027, "National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U2C - Clinical Trial Not Allowed)".

Therefore, Section II., the Award Information section of the FOA has been updated to more accurately reflect the funds available and number of anticipated awards as shown below:

Currently Reads:

Section II. Award Information

Funds Available and Anticipated Number of Awards

NIDDK intends to commit $2,010,000 in FY 2023 to fund three awards.

Award Budget

Application budgets are limited to $425,000 Direct Costs, but need to reflect the actual needs of the proposed project.

Modified to Read (changes shown in bold italics):

Section II. Award Information

Funds Available and Anticipated Number of Awards

NIDDK expects to commit $2,937,000 in FY2023 to fund up to four awards.

Award Budget

Application budgets are limited to $475,000 Direct Costs, but need to reflect the actual needs of the proposed project.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Kristin Abraham, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-8048
Email: kristin.abraham@nih.gov